MADOPAR cpr 125 mg 30 pce
7680435930481
CH-43593
N04BA02
01.08.0.
1 / 3
google
Details
- Product number
- 4359302
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- levodopum 100.00 mg, benserazidum 25.00 mg ut benserazidi hydrochloridum, mannitolum, calcii hydrogenophosphas, cellulosum microcristallinum, amylum pregelificatum, crospovidonum, ethylcellulosum, E 172 (rubrum), silica colloidalis anhydrica, natrii docusas corresp. natrium 0.005 mg, magnesii stearas, pro compresso.
Articles (1)
Madopar 125, Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.005 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 13.45
Specialties list
Yes
Generic
No
SL addition date:
15/03/1988
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 43593
- Drug name
- Madopar, Tabletten
- Galenic form
- TAB
- ATC Code
- N04BA02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 27/01/1981
- Authorization expiration date
- 31/12/9999
- IT number
- 01.08.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MADOPAR cpr 125 mg 30 pce
- Description (DE)
- MADOPAR Tabl 125 mg 30 Stk
- Market launch
- 20/05/1987
- Narcotic (BTM)
- No